Premium Information is available for this item - Upgrade for $1 a day
6505-01-285-2367
Usp Imipenem And Cilastatin For Injection
6505012852367 012852367 NDC00006-3516-75 PRIMAXIN 3516
INC: 66649 Imipenem And Cilastatin For Injection
January 2023
5
Marketplace 6505-01-285-2367
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-285-2367 5+ Documents (More...)
Injection PRIMAXIN Restrictions 6505 NDC00006-3516-75PRIMAXINPRIMAXIN https//www.nsnlookup.com / 6505
PRIMAXIN https //www.nsnlookup.com / 6505-43-001-0028 PRIMAXIN For Injection PRIMAXIN https// https/
https//www.nsnlookup.com / 6505-43-001-0028 PRIMAXIN For Injection PRIMAXIN https//www.nsnlookup.com
PRIMAXIN https//www.nsnlookup.com -0028 PRIMAXIN For Injection PRIMAXIN https// https//www.nsnlookup.com
For Injection PRIMAXIN https//www.nsnlookup.com /fsg-65/fsc-6505/pl 6505-43 PRIMAXIN For Injection PRIMAXIN
https//www.nsnlookup.com / 6505-43-001-0028 PRIMAXIN For Injection PRIMAXIN https//www.nsnlookup.com
Injection 3514-74 Managed by United States NSN Created on 10 May 1986 Data Last Changed January PRIMAXIN
6505-01-611-2256 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-285-2367 Usp Imipenem And Cilastatin
65/fsc-6505/pl 6505-43- https //www.nsnlookup.com /fsg-65/fsc-6505/pl 6505-43-001-0028 232- 3116 PRIMAXIN
https / 6505-43- 001-0028 232- 3116 PRIMAXIN https// https 6505-01-611-2256 https//www.nsnlookup.com
Restrictions 6505-01-285-2367
6505-01-285-2367 is a Usp Imipenem And Cilastatin For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-285-2367
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-285-2367
- MOE Rule:
- V540
- Effective Date:
- 1 Sep 1993
Approved Sources 6505-01-285-2367
- Part Number
- Manufacturer
- Status
- NDC00006-3516-75
- Manufacturer
- 06990 - Merck Sharp & Dohme Corp. (Active)
- Incomplete Reference
- Incomplete Reference
- 3516
- 06990 - Merck Sharp & Dohme Corp. (Active)
- Primary Buy
- Primary Buy
- PRIMAXIN
- 06990 - Merck Sharp & Dohme Corp. (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-285-2367
- Characteristic
- Specifications
- FIIG
- Specifications
- A34300
- Active Medicament Medicinal Strength [AKJA]
- 500.000 Milligrams Cilastatin Equivalent And 500.000 Milligrams Imipenem Equivalent
- Features Provided [CBBL]
- Sterile
- Primary Container Content Quantity [CRLK]
- 1000.000 Milligrams Of Active Ingredient
- Primary Container Type [CQCT]
- Vial
- Physical Form [AGXW]
- Powder
- Total Primary Container Quantity [CSCW]
- 10
Similar Supply Items to 6505-01-285-2367
Freight Information 6505-01-285-2367
6505-01-285-2367 has freight characteristics.. 6505-01-285-2367 has a variance between NMFC and UFC when transported by rail and the description should be consulted.